Finance

Invoicing information for vendors

Invoice Requirements

Information for Ascendis Pharma vendors

To ensure the smooth and expedient handling of vendor invoices, we have listed our invoicing requirements.

Following these requirements:

  • Allows us to pay our bills on time
  • Streamlines the internal authorization process at Ascendis Pharma
  • Reduces manual invoice handling 
  • Reduces the need for clarifying questions to our vendors
  • Keeps Ascendis Pharma in line with internal and external audit requirements
  • Enable Ascendis Pharma to meet domestic and global tax regulations

Ascendis Pharma invoice requirements are listed below. Please be aware, that invoices may be rejected if requirements are not met.

Invoice data requirements Invoice format requirements
  • Vendor full name and address
  • Invoice number and date
  • Payment terms
  • Due date
  • Currency
  • Gross, VAT%*, VAT amount*, Net amount
  • Vendor bank details (or IBAN and SWIFT)
  • Vendor contact email
  • Ascendis Pharma VAT number*
  • PO number (if any)
  • Only one PO per invoice
  • Descriptive invoice text (what is delivered)
  • Reference person in Ascendis Pharma
  • Invoices must be in Adobe Acrobat PDF format 1.3 or higher.
  • Only one invoice per PDF file. However, you can submit several invoices as separate PDF files in one email.
  • Please include any invoice specifications or documentation in the same PDF as the invoice, with the invoice being page 1.
  • Make sure the invoice is readable and has the same format each time. Do not make format changes without an agreement with Ascendis in writing first.

*Only Applicable for Non-US Based Vendors

Forward invoices to the Ascendis Pharma Group company to which goods or services are delivered. See invoice addresses below. Note these mailboxes are automated to only handle PDF invoice attachments. 

 

Company Invoice mail address VAT no.
Ascendis Pharma A/S DK01@ascendispharma.com DK 29 91 87 91
Ascendis Pharma Ophthalmology Division A/S DK02@ascendispharma.com DK 32 32 35 02
Ascendis Pharma Endocrinology Division A/S DK03@ascendispharma.com DK 32 32 35 37
Ascendis Pharma Bone Diseases A/S DK04@ascendispharma.com DK 32 32 35 96
Ascendis Pharma Growth Disorder A/S DK05@ascendispharma.com DK 32 32 36 77
Ascendis Pharma Europe A/S DK08@ascendispharma.com DK 44 42 04 49
Ascendis Pharma Oncology Division A/S DK06@ascendispharma.com DK 41 03 40 76
Ascendis Pharma GmbH DE01@ascendispharma.com DE 813586261
Ascendis Pharma Endocrinology GmbH DE02@ascendispharma.com DE 355769013 
Ascendis Pharma Inc. US01@ascendispharma.com n/a
Ascendis Pharma Endocrinology Inc. US02@ascendispharma.com n/a
Ascendis Pharma France SAS FR01@ascendispharma.com FR43983998436
Ascendis Pharma UK Limited UK01@ascendispharma.com 462312714
Ascendis Pharma Italia SRL IT01@ascendispharma.com IT13523320961
Ascendis Pharma Iberia S.L. ES01@ascendispharma.com ESB56455025

We appreciate your attention to these details. 

Please send all other requests (SOA, reminders etc.) to ACC@ascendispharma.com.

Download these instructions as a PDF

You are about to access www.ascendispharma.com. Click below if you wish to proceed.

You are leaving the UK website to go to Ascendis Pharma’s global website, which is not intended for a UK audience.

You are leaving the UK website to go to Ascendis Pharma’s global website, which is not intended for a UK audience.

You are leaving the UK website to go to Ascendis Pharma’s global website, which is not intended for a UK audience.

You are leaving the UK website to go to Ascendis Pharma’s global website, which is not intended for a UK audience.

You are leaving the UK website to go to Ascendis Pharma’s investors and news website, which is not intended for a UK audience